Rua Diagnostics .

Rua Diagnostics .Rua Diagnostics .
RD

Rua Diagnostics .

Developing a novel, low-cost, point-of-care diagnostic platform for infectious diseases.

Website
2017Active7558Cardiff, United Kingdom
Rate
Advertise here

About

Rua Diagnostics is developing groundbreaking technology using breath analysis with gas chromatography (GC) to enable diagnostic testing for highly prevalent and lethal diseases through a single test. Their investigational BreathScan technology aims to reimagine diagnosis by analyzing breath for conditions like lung cancer, colon cancer, and COVID-19. This technology is currently for investigational use only and not for sale in the US.

Technology stack

detected 2026-07-08
Email
Stack
Observability
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Rua Diagnostics . do?

Rua Diagnostics is developing groundbreaking technology using breath analysis with gas chromatography (GC) to enable diagnostic testing for highly prevalent and lethal diseases through a single test. Their investigational BreathScan technology aims to reimagine diagnosis by analyzing breath for conditions like lung cancer, colon cancer, and COVID-19. This technology is currently for investigational use only and not for sale in the US.

Where is Rua Diagnostics . headquartered?

Rua Diagnostics . is headquartered in Cardiff, United Kingdom.

When was Rua Diagnostics . founded?

Rua Diagnostics . was founded in 2017.

What industry does Rua Diagnostics . operate in?

Rua Diagnostics . operates in MedTech, HealthTech, Diagnostics, Point-of-Care Diagnostics, Infectious Diseases, Biotechnology.

How many employees does Rua Diagnostics . have?

Rua Diagnostics . has approximately 7558 people on record.

What is Rua Diagnostics .'s revenue?

StartupHub estimates Rua Diagnostics .'s annual revenue at $3.7B (range $2.1B to $5.0B, 63% confidence), based on comparable companies in the sector.